Ginkgo Bioworks, headquartered in Boston, specializes in programming cells to produce custom organisms for diverse applications, including agriculture, pharmaceuticals, and industrial biotechnology. Their platform integrates proprietary automation and software, enabling high-throughput organism engineering and the development of innovative biological products. Ginkgo's expertise spans strain improvement, metabolic engineering, and enzyme optimization, facilitating the creation of sustainable solutions across multiple sectors. By leveraging their extensive codebase and foundry capabilities, Ginkgo partners with companies to accelerate research and development, driving advancements in synthetic biology.